Intracoronary adjunctive therapies for ST-elevation myocardial infarction: a network meta-analysis of trials [0.03%]
急性ST段抬高心肌梗死冠脉内治疗的网状meta分析研究
Renzo Laborante,Emiliano Bianchini,Giuseppe Ciliberti et al.
Renzo Laborante et al.
Aims: This network meta-analysis of randomized controlled trials (RCTs) evaluates the comparative safety and efficacy of intra-coronary (IC) pharmacological and procedural treatments - on top of balloon angioplasty and st...
Antithrombotic strategies and DOAC dosing following left atrial appendage occlusion: a network meta-analysis [0.03%]
左心耳闭塞后的抗凝策略和DOAC剂量：网状meta分析
Athanasios Samaras,Paschalis Karakasis,Athanasios Feidakis et al.
Athanasios Samaras et al.
Aims: The optimal short-term antithrombotic strategy following left atrial appendage occlusion (LAAO) remains uncertain, with the need to balance thromboembolic prevention and bleeding risk presenting a critical challenge...
VESALIUS Keeps Revolutionizing Medicine: The Case of Evolocumab in Primary Prevention [0.03%]
Vesalius持续推动医学革命：以依洛尤单抗的一级预防为例
Mattia Galli,Sebastiano Sciarretta,Filippo Crea
Mattia Galli
Reply to 'Sacubitril/Valsartan in Heart Failure: A Critical Look at Dementia Risk and Future Study Pathways' [0.03%]
有关心力衰竭的来信：“沙库必曲/缬沙坦、痴呆风险和未来研究方向的再思考”
Kyungyeon Jung,Ju-Young Shin,Ju Hwan Kim
Kyungyeon Jung
Utilization and discontinuation of secondary prevention pharmacotherapy after myocardial infarction: a nationwide cohort study [0.03%]
心肌梗死后二级预防药物利用和停药的全国队列研究
Ali Yari,Carl-Emil Lim,Emil Hagström et al.
Ali Yari et al.
Aim: To analyze utilization and discontinuation of secondary preventive medications after acute myocardial infarction (MI). Methods: In...
Management of dyslipidaemia in patients with comorbidities: facing the challenge: type 2 diabetes mellitus [0.03%]
合并症患者的血脂管理：迎接挑战：2型糖尿病患者
Heinz Drexel,Andreas Festa,Thomas A Schmidt et al.
Heinz Drexel et al.
Type 2 diabetes mellitus typically has the lipid features of elevated trigycerides, reduced HDL-cholesterol (both parts of the metabolic syndrome) and average or slightly elevated LDL-cholesterol. In consequence of hypertriglyceridemia, LDL...
ODYSSEY-HCM trial (Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy) [0.03%]
ODYSSEY-HCM研究(Mavacamten治疗症状性非梗阻型肥厚型心肌病)
Emanuele Monda,Giuseppe Limongelli
Emanuele Monda
Postoperative atrial fibrillation and stroke after non-cardiac surgery: a systematic review and meta-analysis [0.03%]
非心脏手术后房颤与中风的meta分析及系统性回顾研究
Jacopo Donati,Doralisa Morrone,Freek Verheugt et al.
Jacopo Donati et al.
Background: Postoperative atrial fibrillation (POAF) is common after non-cardiac surgery. Because often transient, there are uncertainties on the associated risk of stroke, possibly driving the need for long-term anticoag...